Intestinal adaptation and Reg gene expression induced by antidiabetic duodenal-jejunal bypass surgery in Zucker fatty rats.
The antidiabetic mechanism of bariatric surgery includes specific changes in the secretion of incretins. To identify additional players originating from the gut, we evaluated the effects of duodenal-jejunal bypass (DJB) in morbidly obese Zucker fatty rats. A fast relief of hyperglycemia and hyperinsulinemia was achieved even before a significant weight loss occurred. Fourteen days after DJB, we characterized the changes in intestinal histochemistry in the bypassed duodenum and shortcut jejunum that was reanastomosed directly to the starting point of the duodenum and compared with the corresponding regions of sham-operated rats. The bypassed duodenum exhibited mucosal atrophy and apoptosis and decreased proliferative renewal. In shortcut jejunum, DJB resulted in 40% significantly enlarged intestinal circumference and increased epithelial proliferation, especially in putative transit-amplifying (TA) cells and the crypt. Because Reg family proteins promote cell growth and survival, we explored their expression in the intestine. With the use of immunohistochemistry, Reg1, -3α, and -3β were normally expressed in intestinal mucosa. After DJB, the level of Reg1 protein was reduced, whereas Reg3α and -3β were not changed in bypassed duodenum. Downstream in shortcut jejunum, the levels of Reg1 and -3β were greatly induced and especially concentrated in the putative TA cells. Our results revealed significant changes in the integrity and proliferation of the intestinal mucosa as a consequence of DJB, and in cell- and isoform-specific expression of Reg proteins within the replicating mucosal epithelium, and provide evidence indicating that the activation of Reg proteins may contribute to intestinal compensation against increased load and/or to improving insulin sensitivity.
Fraser Laboratories for Diabetes Research, Department of Medicine, McGill University Health Centre, Montreal, Canada.
Bing
B
Li
Yarong
Y
Lu
Coimbatore B
CB
Srikant
Zu-Hua
ZH
Gao
Jun-Li
JL
Liu
D000818:Animals; D000951:Antigens, Neoplasm / Q000096:biosynthesis*; D001284:Atrophy / Q000473:pathology; D050110:Bariatric Surgery; D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology / Q000601:surgery; D004386:Duodenum / Q000378:metabolism / Q000473:pathology / Q000601:surgery*; D005951:Glucose Tolerance Test; D007413:Intestinal Mucosa / Q000473:pathology; D007583:Jejunum / Q000378:metabolism / Q000601:surgery*; D037181:Lectins, C-Type / Q000096:biosynthesis*; D051847:Lithostathine / Q000096:biosynthesis*; D008297:Male; D009767:Obesity, Morbid / Q000601:surgery*; D000073718:Pancreatitis-Associated Proteins; D051381:Rats; D011924:Rats, Zucker
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D001786:Blood Glucose; D037181:Lectins, C-Type; D051847:Lithostathine; D000073718:Pancreatitis-Associated Proteins; C497616:Reg1a protein, rat